CVS Health Sees Q1 EPS Estimate Down 1%, Next Year EPS to Rise 13.8%
CVS Health shares gained 4.8% over the past month versus a 1.3% S&P decline and a 2.8% drop in its industry. Q1 EPS estimate was cut 1% to $2.22, current-year forecast of $7.15 is unchanged, next-year EPS forecast rose 13.8% to $8.14.
1. Stock Performance Trends
CVS Health shares climbed 4.8% over the past month, outperforming the S&P composite’s 1.3% decline and outpacing the 2.8% drop in the medical services industry. This relative strength underscores growing investor interest despite mixed near-term outlooks.
2. Earnings Estimate Revisions
Analysts have trimmed the current-quarter EPS forecast by 1% to $2.22, reflecting a 1.3% year-over-year decline. The consensus for the full fiscal year remains at $7.15 (up 5.9% year-over-year), while next year’s EPS estimate of $8.14 reflects 13.8% growth despite a slight 0.2% downward revision in the past month.
3. Recent Results and Surprise History
Last quarter, CVS Health posted revenue of $105.69 billion (up 8.2% year-over-year) and EPS of $1.09 versus $1.19 a year ago. Revenues beat estimates by 2.18% and EPS topped forecasts by 10.1%, marking the fourth consecutive quarter of positive surprises on both metrics.
4. Valuation and Zacks Ranking
The company earns a Value Style Score of A, indicating valuation metrics are attractive relative to peers. Its Zacks Rank of #3 (Hold) suggests the stock may track broader market performance in the near term.